Plx Pharma Inc Asset Turnover Ratio (PLXP), as of third quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Plx Pharma Inc   (NASDAQ: PLXP)
 

Plx Pharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Plx Pharma Inc 's asset turnover ratio, the ratio that measures the ability of Plx Pharma Inc 's assets to generate revenue, sequentially decreased to 0.08 in the third quarter (Sep 30 2022), but it does not raise any concerns as Plx Pharma Inc continue to execute well, and the asset turnover ratio remains above the average.

Within sector 198 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2022 compared to the preceding quarter from 3501 to 3549.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PLXP Asset Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Asset Change -63.72 % -47.79 % -31.13 % 190.66 % 607.29 %
Y / Y Revenue Change -94.17 % - - - -
Asset Turnover Ratio (TTM) 0.08 0.16 0.13 0.1 0.09
PLXP's Total Ranking # 3549 # 3501 # 0 # 0 # 2745
Seq. Asset Change -25.41 % -26.57 % -20.62 % -16.56 % 7.35 %
Seq. Revenue Change -20.08 % -76.81 % 30.85 % -75.94 % -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 199
Healthcare Sector # 544
Overall Market # 3549

Asset Turnover Ratio Statistics
High Average Low
0.16 0.04 -0
(Jun 30 2022)   (Jun 30 2018)




PLXP Company Profile • Back to PLXP Efficiency Comparisons • Compare PLXP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Ani Pharmaceuticals Inc  0.38 $ 282.164  Millions$ 751.722  Millions
Viveve Medical Inc   0.37 $ 6.826  Millions$ 18.560  Millions
Lipocine Inc   0.37 $ 16.611  Millions$ 45.426  Millions
Macrogenics Inc   0.36 $ 92.989  Millions$ 255.020  Millions
Envista Holdings Corporation  0.36 $ 2,360.600  Millions$ 6,504.850  Millions
Heron Therapeutics Inc   0.36 $ 98.299  Millions$ 273.837  Millions
Rayont Inc   0.36 $ 3.521  Millions$ 9.845  Millions
Voyager Therapeutics Inc   0.36 $ 70.531  Millions$ 197.281  Millions
Sonendo Inc   0.35 $ 39.317  Millions$ 111.306  Millions
Sotera Health Company  0.35 $ 993.346  Millions$ 2,818.897  Millions
Becton Dickinson And Company  0.35 $ 18,870.000  Millions$ 53,570.500  Millions
Pacira Biosciences inc   0.35 $ 654.062  Millions$ 1,858.796  Millions
Xencor Inc  0.35 $ 296.985  Millions$ 845.682  Millions
Precipio inc   0.35 $ 9.456  Millions$ 26.984  Millions
Ionis Pharmaceuticals Inc   0.35 $ 875.483  Millions$ 2,502.222  Millions
Neuropace Inc   0.35 $ 43.728  Millions$ 125.391  Millions
Endo International Plc  0.35 $ 2,552.492  Millions$ 7,395.836  Millions
Arrowhead Pharmaceuticals Inc   0.34 $ 243.231  Millions$ 714.361  Millions
United Therapeutics Corporation  0.34 $ 1,860.000  Millions$ 5,463.450  Millions
Orthopediatrics Corp  0.34 $ 116.108  Millions$ 341.566  Millions
Sonida Senior Living Inc   0.34 $ 236.512  Millions$ 699.251  Millions
Medtronic Plc  0.34 $ 30,808.000  Millions$ 91,485.000  Millions
Science 37 Holdings Inc   0.33 $ 74.586  Millions$ 223.257  Millions
Co diagnostics Inc   0.33 $ 53.218  Millions$ 159.967  Millions
Repligen Corp  0.33 $ 801.295  Millions$ 2,412.407  Millions
Innoviva Inc   0.33 $ 373.216  Millions$ 1,124.805  Millions
Avalo Therapeutics Inc   0.33 $ 17.375  Millions$ 52.721  Millions
Illumina Inc   0.33 $ 4,699.000  Millions$ 14,298.750  Millions
Biomarin Pharmaceutical Inc  0.33 $ 2,008.311  Millions$ 6,118.978  Millions
Avid Bioservices Inc   0.33 $ 134.183  Millions$ 409.252  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.